Characterization of a cell surface molecule involved in T-cell activation

1997 ◽  
Vol 56 (1-3) ◽  
pp. 1
Author(s):  
S Tangye
1997 ◽  
Vol 56 ◽  
pp. 1 ◽  
Author(s):  
S.G. Tangye ◽  
G. Aversa ◽  
J.H. Phillips ◽  
J.E. de Vries

1986 ◽  
Vol 16 (10) ◽  
pp. 1289-1296 ◽  
Author(s):  
Werner Lesslauer ◽  
Frits Koning ◽  
Tom Ottenhoff ◽  
Marius Giphart ◽  
Els Goulmy ◽  
...  

1997 ◽  
Vol 186 (2) ◽  
pp. 221-228 ◽  
Author(s):  
X. Charlene Liao ◽  
Sylvie Fournier ◽  
Nigel Killeen ◽  
Arthur Weiss ◽  
James P. Allison ◽  
...  

CD28 is a cell surface molecule that mediates a costimulatory signal crucial for T cell proliferation and lymphokine production. The signal transduction mechanisms of CD28 are not well understood. Itk, a nonreceptor protein tyrosine kinase specifically expressed in T cells and mast cells, has been implicated in the CD28 signaling pathway because of reports that it becomes phosphorylated on tyrosines and associates with CD28 upon cross-linking of the cell surface molecule. To determine whether Itk plays a functional role in CD28 signaling, we compared T cells from Itk-deficient mice and control mice for their responses to CD28 costimulation. T cells defective in Itk were found to be fully competent to respond to costimulation. Whereas the CD3-mediated proliferative response was severely compromised in the absence of Itk, the calcineurin-independent CD28-mediated response was significantly elevated when compared with cells from control animals. The augmented proliferation was not due to increased production of interleukin-2. The results suggest that Itk has distinct roles in the CD3 versus the CD28 signaling pathways. By negatively regulating the amplitude of signaling upon CD28 costimulation, Itk may provide a means for modulating the outcome of T cell activation during development and during antigen-driven immune responses.


1989 ◽  
Vol 19 (8) ◽  
pp. 1431-1436 ◽  
Author(s):  
Françoise Aubrit ◽  
Catherine Gelin ◽  
Danièle Pham ◽  
Brigitte Raynal ◽  
Alain Bernard

1999 ◽  
Vol 112 (4) ◽  
pp. 491-502
Author(s):  
M. Mirabet ◽  
C. Herrera ◽  
O.J. Cordero ◽  
J. Mallol ◽  
C. Lluis ◽  
...  

Extracellular adenosine has a key role in the development and function of the cells of the immune system. Many of the adenosine actions seem to be mediated by specific surface receptors positively coupled to adenylate cyclase: A2A and A2B. Despite the fact that A2A receptors (A2ARs) can be easily studied due to the availability of the specific agonist CGS21680, a pharmacological and physiological characterization of adenosine A2B receptors (A2BRs) in lymphocytes has not been possible due to the lack of suitable reagents. Here we report the generation and characterization of a polyclonal antipeptide antibody raised against the third extracellular loop of the A2BR human clone which is useful for immunocytochemical studies. This antibody has permitted the detection of A2BR+ cells in lymphocyte samples isolated from human peripheral blood. The pharmacology of cAMP-producing compounds is consistent with the presence of functional A2BRs but not of A2A receptors in these human cells. The percentage of A2BR-expressing cells was similar in the CD4(+) or CD8(+) T cell subpopulations. Interestingly activation signals delivered by either phytohemagglutinin or anti-T cell receptor/CD3 complex antibodies led to a significant increase in both the percentage of cells expressing the receptor and the intensity of the labeling. These receptors are functional since interleukin-2 production in these cells is reduced by NECA but not by R-PIA or CGS21680. These results show that A2BR expression is regulated in T cell activation and suggest that the role of adenosine in lymphocyte deactivation is mediated by A2BRs.


Sign in / Sign up

Export Citation Format

Share Document